Evidence map›Paper›PMID 41680413›Full record

ArticleCommunications biology2026

Dissection of innate-immune-ligand- and interferon-protein-mediated transcriptional responses in human THP1 cell states.

Lodoe Lama, Pavel Morozov, Aitor Garzia, Thomas Tuschl

Abstract read
In one paragraph

Article in Communications biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Lodoe LamaLaboratory for RNA Molecular Biology, The Rockefeller University, New York, NY, USA.
Pavel MorozovLaboratory for RNA Molecular Biology, The Rockefeller University, New York, NY, USA.ORCID http://orcid.org/0000-0001-7085-9134
Aitor GarziaLaboratory for RNA Molecular Biology, The Rockefeller University, New York, NY, USA.
Thomas TuschlLaboratory for RNA Molecular Biology, The Rockefeller University, New York, NY, USA. ttuschl@rockefeller.edu.ORCID http://orcid.org/0000-0002-6483-5678

Funding

U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (NIAID) AI141507
6 · The paper itself

Abstract

Interferon regulatory factors (IRFs) are essential for transcription of interferons (IFNs), interferon-stimulated genes (ISGs), and pro-inflammatory cytokines. We profile the transcriptome of human monocyte THP1 cells challenged with cGAMP, LPS, or IFNB1 protein as a function of knockout (KO) or overexpression (OE) of IRFs or KO of IFNAR2. We define distinct gene expression groups, reflecting the transcription factors responsible for their induction including subgroups activated by more than one pathway or feed-forward regulation. We compare IRF3- and IRF7-induced gene signatures and note the strong direct induction of a subset of antiviral-acting ISGs by IRF3 or IRF7. LPS treatment induces NF-κB responses in monocyte and macrophage state cells, however, IFNs and ISGs are only co-induced in the macrophage state requiring IRF3. IRF1, IRF2, IRF5, and IRF8 are largely dispensable for IFN-stimulated or innate-immune-mediated gene induction. This study provides a valuable resource for dissecting complex inflammatory gene signatures and their underlying transcription factors thereby anticipating the effects of selectively drugging the underlying pathways.

Indexed as

Immunity, InnateInterferon Regulatory FactorsInterferonsTranscription, GeneticGene Expression RegulationHumansInterferon Regulatory Factor-3LigandsMacrophagesMonocytesSignal TransductionTHP-1 CellsInterferon Regulatory Factor-3Interferon Regulatory FactorsInterferonsIRF3 protein, humanLigands

Identifiers

PMID41680413
PMCPMC12901304

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.